Topics

"High throughput reformatting phage displayed antibody fragments IgGs" Drugs and Medication Database

18:20 EDT 20th July 2019 | BioPortfolio

Here are the most relevant "High throughput reformatting phage displayed antibody fragments IgGs" Drugs and Medications that we have found in our database.

More Information about "High throughput reformatting phage displayed antibody fragments IgGs" on BioPortfolio

We have published hundreds of High throughput reformatting phage displayed antibody fragments IgGs news stories on BioPortfolio along with dozens of High throughput reformatting phage displayed antibody fragments IgGs Clinical Trials and PubMed Articles about High throughput reformatting phage displayed antibody fragments IgGs for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of High throughput reformatting phage displayed antibody fragments IgGs Companies in our database. You can also find out about relevant High throughput reformatting phage displayed antibody fragments IgGs Drugs and Medications on this site too.

Showing "High throughput reformatting phage displayed antibody fragments IgGs" Drugs and Medications 1–25 of 25

Possibly Relevant

Sodium chloride [baxter healthcare corporation]

0.9% Sodium Chloride Irrigation, USP in ARTHROMATIC Plastic Container

Digifab [btg international inc.]

These highlights do not include all the information needed to use DIGIFAB safely and effectively. See full prescribing information for DIGIFAB . DigiFab , Digoxin Immune Fab (Ovine) For Intravenous Injection Only – Lyophilized Powder for Solution IIniti

Campath [genzyme corporation]

These highlights do not include all the information needed to use CAMPATH safely and effectively. See full prescribing information for CAMPATH. CAMPATH (alemtuzumab) Injection for intravenous useInitial U.S. Approval: 2001

Digifab [savage laboratories, a division of nycomed us inc.]

DIGIFAB DIGOXIN IMMUNE FAB (OVINE)

Tysabri [biogen inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI.TYSABRI (natalizumab) injection, for intravenous useInitial U.S. Approval: 2004

Oxtellar xr [supernus pharmaceuticals, inc.]

These highlights do not include all the information needed to use OXTELLAR XR safely and effectively. See full prescribing information for OXTELLAR XR. OXTELLAR XR (oxcarbazepine) extended-release tablets, for oral use Initial U.S. Approval: 2000

Tymlos [radius health, inc.]

These highlights do not include all the information needed to use TYMLOS safely and effectively. See full prescribing information for TYMLOS. TYMLOS (abaloparatide) injection, for subcutaneous use Initial U.S. Approval: 2017

Xiaflex [endo pharmaceuticals, inc.]

These highlights do not include all the information needed to use XIAFLEX safely and effectively. See full prescribing information for XIAFLEX. XIAFLEX (collagenase clostridium histolyticum) for injection, for intralesional use Initial U.S. Approval: 2010

Aimovig [amgen inc]

These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018

Zinplava [merck sharp & dohme corp.]

These highlights do not include all the information needed to use ZINPLAVA safely and effectively. See full prescribing information for ZINPLAVA. ZINPLAVA™ (bezlotoxumab) injection, for intravenous use Initial U.S. Approval: 2016

Lactated ringers [baxter healthcare corporation]

Lactated Ringer’s Irrigationin ARTHROMATIC Plastic Container

Emgality [eli lilly and company]

These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY.EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018

Lopinavir-ritonavir [lannett company, inc.]

These highlights do not include all the information needed to use use LOPINAVIR AND RITONAVIR ORAL SOLUTION safely and effectively. See full prescribing information for LOPINAVIR AND RITONAVIR ORAL SOLUTION. LOPINAVIR AND RITONAVIR solution, for oral

Isentress [remedyrepack inc.]

These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS (raltegravir) film-coated tablets, for oral use ISENTRESS HD (raltegravir) film-coated tablets, f

Ajovy [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY.AJOVY (fremanezumab-vfrm) injection, for subcutaneous useInitial U.S. Approval: 2018

Cerezyme [genzyme corporation]

NA

Fasenra [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use FASENRA safely and effectively. See full prescribing information for FASENRA.FASENRA (benralizumab) injection, for subcutaneous useInitial U.S. Approval: 2017

Byetta [physicians total care, inc.]

These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA (exenatide) Injection Initial U.S. Approval: 2005

Takhzyro [dyax corp.]

These highlights do not include all the information needed to use TAKHZYRO™ safely and effectively. See full prescribing information for TAKHZYRO™. TAKHZYRO™ (lanadelumab-flyo) injection, for subcutaneous use.Initial U.S. Approval: 2018.

Sovaldi [gilead sciences, inc.]

These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. SOVALDI(sofosbuvir) tablets, for oral use Initial U.S. Approval: 2013

Invirase [state of florida doh central pharmacy]

INVIRASE (saquinavir mesylate) CAPSULES and TABLETS

E-z-disk [e-z-em, inc.]

NDC 10361-778-31E-Z-DISK™(Barium Sulfate Tablets)700 mg

Sovaldi access [gilead sciences, inc.]

These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. GILEAD ACCESS PROGRAM SOVALDI™ (sofosbuvir) tablets, for oral use Initial U.S. Approval: 2013

Adlyxin [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use ADLYXIN safely and effectively. See full prescribing information for ADLYXIN. ADLYXIN (lixisenatide) injection, for subcutaneous use Initial U.S. Approval: 2016

Octagam immune globulin (human) [octapharma pharmazeutika produktionsgesellschaft m.b.h.]

Octagam, Immune Globulin Intravenous (Human) 5% Liquid Preparation Initial U.S. Approval: 2004 - These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing i



Quick Search